One company to consider adding to your watch list is Mannkind, MNKD. Upgraded to "market outperform" at Motley Fool yesterday.
Company has secured financing to operate through Afrezza's approval. A big pharma partnership could happen at any time.
At under $2.00 a share currently now may be a good time to add a few shares to your portfolio for the approval run-up.